Ibrance
NDC 0069-0187, palbociclib, capsule, from Pfizer Laboratories Div Pfizer Inc.
- Product NDC
- 0069-0187
- Status
- Listed
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA207103
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0069-0187 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PALBOCICLIB75 mg/1
Pharmacologic classes
Cytochrome P450 3A Inhibitors [MoA]; Kinase Inhibitor [EPC]; Kinase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0069-0187-21 | 00069018721 | 21 CAPSULE in 1 BOTTLE (0069-0187-21) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/e0e6412f-50b4-4fd4-9364-62818d121a07
Use it
Look up 0069-0187 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0069-0187 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0069-0187. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.